Discovery to Commercialization Program for Substance Abuse Prevention and Treatment (D2C: SAPT)
药物滥用预防和治疗发现到商业化计划(D2C:SAPT)
基本信息
- 批准号:10665788
- 负责人:
- 金额:$ 32.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:Active LearningAddressAdvocateAwardBasic ScienceBusinessesCaringClinicClinicalClinical SciencesClinical TreatmentCommunitiesComplementDiagnosisDisabled PersonsEducationEducational CurriculumEducational process of instructingEducational workshopEnrollmentEnsureEntrepreneurshipEvaluationExposure toFeedbackFosteringFundingFutureGenerationsGoalsGrantHealthIndividualInstructionIntellectual PropertyKnowledgeLearningLegal patentLicensingMarketingMeasuresMentorsModelingParticipantPathway interactionsPatient RecruitmentsPatientsPersonsPopulationPositioning AttributePreventionProblem SolvingProcessProfessional EducationProviderPublic HealthRecruitment ActivityResearchResearch PersonnelResource SharingResourcesSchoolsScienceScientistSubstance Use DisorderTimeTrainingTraining ProgramsTranslationsUnderrepresented PopulationsUniversitiesWorkcareercertificate programclinical practicecommercializationcommunity buildingdesigneducation resourcesempowermentevidence baseexperienceideationimprovedinnovationinstructorinterestmeetingsnext generationonline communityprogramsprototyperecruitrole modelsatisfactionscaffoldservice providersskills trainingstemsubstance abuse preventionsubstance abuse treatmentsubstance use treatmentsynchronous contacttoolvirtual
项目摘要
Project Summary
There has been critical underinvestment in Substance Use Disorders (SUDs) and continuing to rely on
the same approaches is not working. In this proposal, we actively seek to support disruptive innovations to
stem the rising tide of SUDs and stimulate progress. Such disruptions are most likely to come from those
actively engaged in treating and advancing knowledge of SUDs. But many in a position to do so are not aware
of or see value in discovery commercialization. Our overarching goals are to have more basic scientists think
like entrepreneurs and to have access to the resources they need to engage in the commercialization
processes. Through our proposed tasks, we will develop and deliver entrepreneurship education that is curated
for basic science researchers, empowering them with the tools they need to commercialize their discoveries,
disruptively innovate, and advance the prevention, diagnosis, and treatment of SUDs.
The Discovery to Commercialization Program for Substance Abuse Prevention and Treatment
(D2C: SAPT) curriculum will be systematically developed, implemented, and evaluated during this 5-year grant
period. The cornerstone of the proposed initiative is a new Certificate in Entrepreneurship at the Johns
Hopkins University Carey Business School (Aim 2). This program will leverage our experience in teaching
entrepreneurship to scientists at Johns Hopkins and be customized to SUD researchers. The asynchronous
online modules developed for the certificate program will be distributed widely (Aim 1), and through our
educational efforts we will intentionally build (Aim 3) and diversify (Aim 4) the community that can support
translation of discovery to market and impact SUDs.
This will be a specialized program for SUD researchers aimed at scientists at all career levels that is
grounded in theoretical frameworks and complemented by professional education related to entrepreneur
identity formation and community building. D2C: SAPT will comprise three parts: asynchronous modules
consisting of topics in ideation, market discovery, intellectual property, regulatory strategy, business, and
financial modeling, an in-person multi-day workshop comprising observations in SUD clinics, conversations
with stakeholders, design, and prototyping, and a mentored experiential learning component culminating in a
pitch competition. Program graduates will be equipped to apply for translational funding, patents, and to license
intellectual property or launch companies. More broadly, they will be part of a large virtual community of
researchers and practitioners and will play a role in transforming the culture of academic scientists. With a
keen understanding of the gaps that exist in the SUD field, the types of innovations that are possible, and the
process needed to train scientists in moving their discoveries to market, this training program will have
substantial public health impact by facilitating the launch of projects that move clinical practice in SUD to the
next generation of solutions.
项目摘要
对物质使用障碍(SUD)的投资严重不足,并继续依赖
同样的方法不起作用。在这份提案中,我们积极寻求支持颠覆性创新,
阻止SUD的上升趋势并刺激进步。这种破坏最有可能来自那些
积极参与治疗和提高SUD的知识。但许多有能力这样做的人并不知道,
具有或看到发现商业化的价值。我们的首要目标是让更多的基础科学家思考
像企业家一样,并获得他们参与商业化所需的资源,
流程.通过我们提出的任务,我们将开发和提供创业教育,
为基础科学研究人员,赋予他们所需的工具,使他们的发现商业化,
颠覆性创新,推进SUD的预防、诊断和治疗。
药物滥用预防和治疗的发现到商业化计划
(D2C:SAPT)课程将在这5年的资助期间得到系统的开发、实施和评估
期该计划的基石是约翰商学院新的创业证书
霍普金斯大学凯里商学院(目标2)。该计划将利用我们的教学经验
企业家精神的科学家在约翰霍普金斯和定制的南加州大学的研究人员。异步
为证书计划开发的在线模块将广泛分发(目标1),并通过我们的
我们将有意识地建立(目标3)和多样化(目标4)能够支持的社区
将发现转化为市场和影响SUD。
这将是一个专门的计划,为南加州大学的研究人员在所有职业水平的科学家,
以理论框架为基础,并辅之以与企业家有关的专业教育
身份形成和社区建设。D2C:SAPT将包括三个部分:异步模块
包括构思、市场发现、知识产权、监管策略、商业和
金融建模,包括在SUD诊所观察,对话,
与利益相关者,设计和原型设计,以及一个指导的体验式学习组件,最终在一个
球场竞争课程毕业生将有能力申请翻译资金,专利和许可证
知识产权或发射公司。更广泛地说,他们将成为一个大型虚拟社区的一部分,
研究人员和从业人员,并将在改变学术科学家的文化中发挥作用。与
对SUD领域存在的差距、可能的创新类型以及
培训科学家将其发现推向市场所需的过程,该培训计划将
通过促进启动将SUD的临床实践转移到
下一代解决方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelly E Dunn其他文献
The IMPOWR Network Divided or Single Exposure Study (DOSE) Protocol: A Randomized Controlled Comparison of Once Versus Split Dosing of Methadone for the Treatment of Comorbid Chronic Pain and Opioid Use Disorder.
IMPOWR 网络分次或单次暴露研究 (DOSE) 方案:一次与分次给药美沙酮治疗共病慢性疼痛和阿片类药物使用障碍的随机对照比较。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Greer McKendrick;Will Davis;Michael Sklar;Nicole Brown;Emma Pattillo;Patrick H. Finan;Denis Antoine;Vickie Walters;Kelly E Dunn - 通讯作者:
Kelly E Dunn
The Public Health Challenge of Δ8-THC and Derived Psychoactive Cannabis Products.
Δ8-THC 和衍生的精神活性大麻产品的公共卫生挑战。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Jennifer M Whitehill;Kelly E Dunn;Renee M Johnson - 通讯作者:
Renee M Johnson
Kelly E Dunn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kelly E Dunn', 18)}}的其他基金
Discovery to Commercialization Program for Substance Abuse Prevention and Treatment (D2C: SAPT)
药物滥用预防和治疗发现到商业化计划(D2C:SAPT)
- 批准号:
10524311 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Randomized Clinical Trial Intervention to Treat Chronic Pain Among Persons Maintained on Methadone for Opioid Use Disorder
随机临床试验干预治疗因阿片类药物使用障碍而维持美沙酮治疗的慢性疼痛
- 批准号:
10624868 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Randomized Clinical Trial Intervention to Treat Chronic Pain Among Persons Maintained on Methadone for Opioid Use Disorder
随机临床试验干预治疗因阿片类药物使用障碍而维持美沙酮治疗的慢性疼痛
- 批准号:
10458799 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
评估具有临床意义的阿片类药物戒断表型
- 批准号:
10580802 - 财政年份:2021
- 资助金额:
$ 32.05万 - 项目类别:
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
评估具有临床意义的阿片类药物戒断表型
- 批准号:
10401839 - 财政年份:2021
- 资助金额:
$ 32.05万 - 项目类别:
Evaluating Suvorexant for Sleep Disturbance in Opioid Use Disorder
评估 Suvorexant 对阿片类药物使用障碍患者睡眠障碍的影响
- 批准号:
9899225 - 财政年份:2019
- 资助金额:
$ 32.05万 - 项目类别:
Evaluating Suvorexant for Sleep Disturbance in Opioid Use Disorder
评估 Suvorexant 对阿片类药物使用障碍患者睡眠障碍的影响
- 批准号:
9790420 - 财政年份:2019
- 资助金额:
$ 32.05万 - 项目类别:
Evaluating Suvorexant for Sleep Disturbance in Opioid Use Disorder
评估 Suvorexant 对阿片类药物使用障碍患者睡眠障碍的影响
- 批准号:
10454583 - 财政年份:2019
- 资助金额:
$ 32.05万 - 项目类别:
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
A118G SNP 和 OPRM1 基因阿片类药物介导的人类作用
- 批准号:
8925834 - 财政年份:2014
- 资助金额:
$ 32.05万 - 项目类别:
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
A118G SNP 和 OPRM1 基因阿片类药物介导的人类作用
- 批准号:
8594898 - 财政年份:2014
- 资助金额:
$ 32.05万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 32.05万 - 项目类别:
Research Grant